PubRank

P Théroux

Author PubWeight™ 104.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979 4.04
2 The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group. CMAJ 1998 3.30
3 Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 1998 2.72
4 Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999 2.38
5 Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J Am Coll Cardiol 1999 2.13
6 Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000 2.13
7 Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996 1.99
8 A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990 1.93
9 Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001 1.83
10 Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981 1.71
11 Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991 1.56
12 Antithrombotic agents in coronary artery disease. Chest 2001 1.53
13 A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). Eur Heart J 2000 1.51
14 Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J 2002 1.50
15 Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol 1992 1.48
16 Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol 1991 1.41
17 Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Thromb Haemost 1999 1.39
18 A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001 1.37
19 Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 2000 1.31
20 Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction. J Am Coll Cardiol 1985 1.24
21 Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 1999 1.19
22 Left main stenting-as a bridge to surgery-for acute type A aortic dissection and anterior myocardial infarction. Catheter Cardiovasc Interv 2000 1.09
23 Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol 1990 1.08
24 Pulsed doppler echocardiographic study of mitral stenosis. Circulation 1980 1.05
25 Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ 2001 1.04
26 Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol 1984 1.03
27 Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. Am J Cardiol 1984 1.01
28 Long-term prognosis of patients with variant angina. Circulation 1987 1.01
29 Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992 1.00
30 Unstable angina and progression of coronary atherosclerosis. N Engl J Med 1983 0.97
31 Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 1983 0.97
32 Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina. Circulation 1979 0.97
33 Clinical characteristics associated with sudden death in patients with variant angina. Circulation 1982 0.96
34 Prognostic significance of progression of coronary artery disease. Am J Cardiol 1985 0.96
35 Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 1987 0.95
36 Evaluation of the Newton Pen-Pad as a tool for collecting clinical research data at the bed-side. Proc AMIA Annu Fall Symp 1996 0.94
37 Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes. Circulation 1995 0.94
38 Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987 0.94
39 A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985 0.93
40 Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation 1999 0.93
41 Calcium antagonists. Clinical use in the treatment of angina. Drugs 1983 0.92
42 Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects. Circulation 1993 0.92
43 Coronary artery spasm during exercise in patients with variant angina. Circulation 1979 0.91
44 Antithrombotic agents in coronary artery disease. Chest 1998 0.91
45 Cell-to-cell interaction: a mechanism to explain wave-front progression of myocardial necrosis. Am J Physiol 1989 0.90
46 Factors influencing the long-term prognosis of treated patients with variant angina. Circulation 1983 0.90
47 Exercise testing in patients with variant angina: results, correlation with clinical and angiographic features and prognostic significance. Circulation 1982 0.89
48 Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998 0.87
49 Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation 1985 0.87
50 Exercise stress testing in the post-myocardial infarction patient. Am J Cardiol 1983 0.86
51 Angiographic findings after myocardial infarction in patients with previous bypass surgery: explanations for smaller infarcts in this group compared with control patients. Circulation 1985 0.86
52 Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries. Am J Cardiol 1985 0.86
53 S-T segment elevation and coronary spasm in response to exercise. Am J Cardiol 1981 0.86
54 Early postinfarction ischemia: clinical, angiographic, and prognostic significance. Circulation 1987 0.86
55 Myocardial cell protection : a challenging time for action and a challenging time for clinical research. Circulation 2000 0.85
56 Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 2001 0.85
57 Ventricular arrhythmias during ergonovine-induced episodes of variant angina. Am Heart J 1984 0.85
58 Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. Am J Cardiol 1990 0.84
59 Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty. Circulation 2000 0.84
60 Clinical outcomes of bivalirudin for ischemic heart disease. Circulation 1999 0.84
61 The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes. Clin Cardiol 1997 0.84
62 Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction. J Am Coll Cardiol 1986 0.83
63 Clinical manifestations and pathophysiology of myocardial ischemia with special reference to coronary artery spasm and the role of slow channel calcium blockers. Prog Cardiovasc Dis 1982 0.83
64 Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina. Am J Cardiol 1981 0.82
65 Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size. Am J Physiol 1992 0.82
66 Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol 1988 0.82
67 Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients. Am J Cardiol 1987 0.81
68 Left main coronary artery stenosis in young patients. Chest 1979 0.81
69 Whither the coronary care unit? CMAJ 1987 0.81
70 A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction. Circulation 1994 0.81
71 Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation 1992 0.81
72 Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol 1996 0.80
73 Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). Am Heart J 2001 0.80
74 Recurrence of Prinzmetal angina seven years following aortocoronary bypass surgery: a clinical and angiographic follow-up. Cathet Cardiovasc Diagn 1979 0.80
75 Methylene blue inhibits the antithrombotic effect of nitroglycerin. J Am Coll Cardiol 1993 0.80
76 Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993 0.79
77 Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol 1986 0.79
78 Influence of tachycardia and arterial hypertension on infarct size in the pig. Cardiovasc Res 1988 0.79
79 Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel. Br J Pharmacol 2012 0.79
80 Exercise testing in the early period after myocardial infarction in the evaluation of prognosis. Cardiol Clin 1984 0.79
81 Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts. J Am Coll Cardiol 1987 0.79
82 Spontaneous regression of coronary artery obstructions: incidence in 313 consecutive repeat angiograms. Cathet Cardiovasc Diagn 1985 0.79
83 Five- to ten-year outcome after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol 1993 0.78
84 Coronary angiographic significance of left anterior fascicular block during acute myocardial infarction. J Am Coll Cardiol 1985 0.78
85 Hemodynamic effects of calcium ion antagonists after acute myocardial infarction. Clin Invest Med 1980 0.78
86 Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. Int J Cardiol 1999 0.78
87 Detection and assessment of unstable angina using myocardial perfusion imaging: comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram. Am J Cardiol 1990 0.78
88 A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol 2001 0.78
89 Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1998 0.77
90 Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1995 0.77
91 'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease. Coron Artery Dis 1998 0.77
92 Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris. Am J Cardiol 1994 0.77
93 Antithrombotic agents in coronary artery disease. Chest 1995 0.77
94 Late (> 48 hr) myocardial infarction after PTCA: clinical and angiographic characteristics of infarction related or not to the angioplasty site. Catheter Cardiovasc Interv 2001 0.77
95 Antithrombin-III plasma activity during and after prolonged use of heparin in unstable angina. Thromb Res 1993 0.76
96 Antithrombotic agents in coronary artery disease. Chest 1992 0.76
97 Action of nifedipine in ischemic heart disease. Can Fam Physician 1983 0.75
98 Hemodynamic and therapeutic effects of intravenous dopamine. Can Med Assoc J 1977 0.75
99 Angiographic and clinical progression in unstable angina. From clinical observations to clinical trials. Circulation 1995 0.75
100 High risk patient after recovery from myocardial infarction. J Am Coll Cardiol 1983 0.75
101 Myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol 1984 0.75
102 New antithrombotics. Chest 1995 0.75
103 Refractory variant angina controlled with combined drug therapy in a patient with a single coronary artery. Cathet Cardiovasc Diagn 1980 0.75
104 Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance. Circ Res 1983 0.75
105 Is progression of coronary artery disease occurring at bouts or as a continuous process? Serial cineangiographic studies in 44 patients. Comput Biomed Res 1984 0.75
106 [Prehospital fibrinolysis: a priority objective?]. Rev Esp Cardiol 1992 0.75
107 Improved gas chromatographic determination of diltiazem and deacetyldiltiazem in human plasma. J Pharm Sci 1984 0.75
108 Late development of left ventricular outflow tract obstruction after repair of double-outlet right ventricle. J Thorac Cardiovasc Surg 1976 0.75
109 [Myocardial infarction with cardiogenic shock in the young adult (author's transl)]. Ann Cardiol Angeiol (Paris) 1980 0.75
110 A comparative study of calcium-ion antagonists in patients with variant angina. Clin Invest Med 1980 0.75
111 [Must the medical treatment of vasospastic angina be continued indefinitely?]. Arch Mal Coeur Vaiss 1983 0.75
112 [Can the prognosis of myocardial infarction be determined at discharge from the hospital?]. Rev Prat 1987 0.75
113 High-performance liquid chromatographic determination of diltiazem and six of its metabolites in human urine. J Pharm Sci 1984 0.75
114 [Complete medical records on a computer card: dream or reality?]. Nurs Que 1987 0.75
115 A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome. Int J Card Imaging 1994 0.75
116 Evaluation of prognosis 1 year after myocardial infarction. J Am Coll Cardiol 1984 0.75
117 Role of diltiazem in the treatment of silent myocardial ischemia. J Cardiovasc Pharmacol 1991 0.75
118 Effects of diltiazem on atrioventricular conduction and arterial blood pressure: correlation with plasma drug concentrations. Can J Physiol Pharmacol 1984 0.75
119 Newer concepts in the treatment of unstable angina pectoris. Am J Cardiol 1991 0.75
120 [Hereditary intolerance to fructose. Clinical and biochemical study]. Union Med Can 1976 0.75
121 [Unstable angina at the crossroads]. Rev Esp Cardiol 1987 0.75
122 Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes. Eur Heart J 2000 0.75
123 [Pulmonary capillary pressure studied with pulsed Doppler technic]. Union Med Can 1983 0.75
124 Unstable angina: special considerations in the postbypass patient. Cardiovasc Clin 1991 0.75
125 [Doppler echocardiography in the non-invasive assessment of the permeability of aorto-coronary bypass]. Arch Mal Coeur Vaiss 1980 0.75
126 A pathophysiologic basis for the clinical classification and management of unstable angina. Circulation 1987 0.75
127 Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group. Am J Cardiol 1992 0.75
128 Failure of ketanserin, a serotonin inhibitor, to prevent spontaneous or ergonovine-induced attacks of variant angina. Can J Cardiol 1985 0.75
129 [Vasodilator agents in the treatment of acute and chronic cardiac insufficiency]. Union Med Can 1979 0.75
130 Prostaglandin E1 increases myocardial contractility in the conscious dog. Can J Physiol Pharmacol 1984 0.75
131 [Secondary prevention following a myocardial infarct]. Union Med Can 1983 0.75
132 Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty. Chest 1992 0.75
133 Clinical and angiographic features and prognostic significance of early postinfarction angina with and without electrocardiographic signs of transient ischemia. Am J Med 1991 0.75
134 The systolic stress-volume relationship. Circulation 1983 0.75
135 [Coronary spasm and the ergonovine test. Clinical applications]. Arch Mal Coeur Vaiss 1980 0.75
136 [Usefulness and risk of ergonovine testing in Prinzmetal's angina]. Union Med Can 1979 0.75
137 [Coronary disease and calcium antagonists]. Union Med Can 1979 0.75
138 Chronic oral vasodilator therapy to control heart failure in postinfarction ventricular septal defect. Cathet Cardiovasc Diagn 1979 0.75
139 Intracoronary infusion of superoxide dismutase and reperfusion injury in the pig heart. Basic Res Cardiol 1991 0.75
140 [Calcium antagonists: pharmacological effects and therapeutic indications]. Union Med Can 1983 0.75
141 [Objective evaluation of calcium antagonists in Prinzmetal's angina with the ergonovine test]. Arch Mal Coeur Vaiss 1983 0.75
142 The ergonovine test--to catch a leprechaun. Int J Cardiol 1984 0.75
143 [Prospective randomized study of the therapeutic action of propranolol compared to diltiazem in unstable stenocardia]. Ter Arkh 1982 0.75
144 [Usefulness of 24-hour electrocardiographic monitoring in the treatment of patients with Prinzmetal's angina]. Union Med Can 1983 0.75
145 [Amenorrhea-galactorrhea and thyroid pathology]. Union Med Can 1972 0.75
146 Unstable angina--report from a Canadian expert roundtable. Can J Cardiol 1996 0.75
147 Problems related to the detection of myocardial ischemia caused by coronary vasospasm. Can J Cardiol 1986 0.75